The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Bisphosphonates and other bone agents for breast cancer
|
---|---|
Published by |
John Wiley & Sons, Ltd, February 2012
|
DOI | 10.1002/14651858.cd003474.pub3 |
Pubmed ID | |
Authors |
Wong, Matthew HF, Stockler, Martin R, Pavlakis, Nick |
Abstract |
Bone is the most common site of metastatic disease associated with breast cancer (BC). Bisphosphonates inhibit osteoclast-mediated bone resorption, and novel targeted therapies such as denosumab, inhibit key pathways in the vicious cycle of bone metastases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Greenland | 1 | 17% |
Mexico | 1 | 17% |
Colombia | 1 | 17% |
Unknown | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 1% |
Spain | 1 | <1% |
France | 1 | <1% |
Canada | 1 | <1% |
Unknown | 173 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 33 | 19% |
Student > Master | 25 | 14% |
Student > Ph. D. Student | 20 | 11% |
Other | 18 | 10% |
Student > Bachelor | 16 | 9% |
Other | 30 | 17% |
Unknown | 36 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 91 | 51% |
Agricultural and Biological Sciences | 8 | 4% |
Nursing and Health Professions | 8 | 4% |
Psychology | 5 | 3% |
Biochemistry, Genetics and Molecular Biology | 3 | 2% |
Other | 13 | 7% |
Unknown | 50 | 28% |